14-23382430-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PVS1_ModerateBS2
The NM_002471.4(MYH6):c.5794A>T(p.Lys1932*) variant causes a stop gained, splice region change. The variant allele was found at a frequency of 0.0000613 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K1932K) has been classified as Uncertain significance.
Frequency
Consequence
NM_002471.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH6 | NM_002471.4 | c.5794A>T | p.Lys1932* | stop_gained, splice_region_variant | Exon 38 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH6 | ENST00000405093.9 | c.5794A>T | p.Lys1932* | stop_gained, splice_region_variant | Exon 38 of 39 | 5 | NM_002471.4 | ENSP00000386041.3 | ||
MYH6 | ENST00000651452.1 | n.1021A>T | splice_region_variant, non_coding_transcript_exon_variant | Exon 2 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251478Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135912
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461868Hom.: 0 Cov.: 33 AF XY: 0.0000523 AC XY: 38AN XY: 727240
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74316
ClinVar
Submissions by phenotype
not provided Uncertain:2
Nonsense variant predicted to result in protein truncation as the last 8 amino acids are lost in a gene for which loss-of-function is not an established mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30293987, 28991257) -
PVS1_moderate -
Hypertrophic cardiomyopathy 14 Uncertain:1
This sequence change creates a premature translational stop signal (p.Lys1932*) in the MYH6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 8 amino acid(s) of the MYH6 protein. This variant is present in population databases (rs763914096, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with structural heart defects (PMID: 28991257, 30293987). ClinVar contains an entry for this variant (Variation ID: 566642). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Dilated cardiomyopathy 1EE;C2750467:Hypertrophic cardiomyopathy 14;C3279790:Atrial septal defect 3;C3279791:Sick sinus syndrome 3, susceptibility to;C3495498:Hypertrophic cardiomyopathy 1 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.K1932* variant (also known as c.5794A>T), located in coding exon 36 of the MYH6 gene, results from an A to T substitution at nucleotide position 5794. This changes the amino acid from a lysine to a stop codon within coding exon 36. This variant has been identified in the homozygous state and/or in conjunction with other MYH6 variant(s) in individual(s) with features consistent with congenital heart defects (Jin SC et al. Nat Genet, 2017 Nov;49:1593-1601; Alankarage D et al. Genet Med, 2019 05;21:1111-1120). This alteration occurs at the 3' terminus of theMYH6 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 8 amino acids of the protein. The exact functional effect of this alteration is unknown. In addition, loss of function of MYH6 has not been established as a mechanism of disease. Based on the available evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at